Wealthspire Advisors (Maryland)’s Impax Laboratories, Inc. IPXL Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-457	Closed	-$9K	–	2697
2018 Q1	$9K	Sell	457 -171	-27%	-$3.36K	﹤0.01%	1632
2017 Q4	$10K	Buy	628 +257	+69%	+$4.71K	﹤0.01%	1607
2017 Q3	$8K	Buy	371 +17	+5%	+$325	﹤0.01%	1673
2017 Q2	$6K	Hold	354	–	–	﹤0.01%	1742
2017 Q1	$4K	Buy	+354	New	+$4.28K	﹤0.01%	1598

Wealthspire Advisors (Maryland)'s IPXL Position: Q2 2018 in Review

Wealthspire Advisors (Maryland) sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 457 shares — an estimated $9K sold.

Wealthspire Advisors (Maryland) first reported a position in IPXL in Q1 2017 and held it in 5 quarters. The position peaked at $10K in Q4 2017. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Wealthspire Advisors (Maryland) reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Wealthspire Advisors (Maryland) sold 457 Impax Laboratories, Inc. shares in Q2 2018, an estimated $9K.
Wealthspire Advisors (Maryland) first reported a position in Impax Laboratories, Inc. in Q1 2017 and held it in 5 quarters.
Wealthspire Advisors (Maryland)'s Impax Laboratories, Inc. position peaked at $10K in Q4 2017.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2018, filed 8 Aug 2018.